<DOC>
	<DOCNO>NCT02050048</DOCNO>
	<brief_summary>The purpose study examine whether give large amount intravenous ( IV ) fluids reduce risk develop complication know post-ERCP pancreatitis ( PEP ) . Pancreatitis inflammation pancreas , frequent serious complication ERCP . Typically , small amount IV fluid give procedure ( ~ 1 liter ) . We test whether use large amount fluid ( 2 - 3 liter ) reduce risk PEP .</brief_summary>
	<brief_title>High Volume Lactated Ringer 's Solution Pancreatitis</brief_title>
	<detailed_description>This trial design phase II/III study . The phase II portion trial complete establish safety efficacy data prior proceed phase III study . The phase II trial enroll 110 patient undergoing elective ERCP outpatient . Following phase II portion , data suggest intervention arm ( high volume group ) safe , investigator begin enrol patient undergo ERCP urgent setting inpatient . We plan enrol 1,400 consecutive high risk patient undergo ERCP . We assume baseline PEP risk 9.2 % . Fluid administration base Ideal Body Weight ( IBW ) order standardize aggressive fluid administration across body weight reduce potential adverse cardiopulmonary outcome . All participant monitor 90 minute follow procedure ass development adverse symptom . Analysis data safety monitoring board ( DSMB ) take place throughout study . The DSMB comprise panel expert independent NorthShore University HealthSystem .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Patients include study undergo ERCP follow : Clinical suspicion sphincter Oddi dysfunction History postERCP pancreatitis ( least one episode ) Pancreatic sphincterotomy Precut ( access ) sphincterotomy Ampullectomy Age &lt; 18 year old Intrauterine pregnancy breastfeed mother Congestive heart failure Advanced/symptomatic coronary artery disease Known ascites Renal failure Active recent gastrointestinal hemorrhage Acute pancreatitis within 72 hour prior ERCP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Pancreatitis</keyword>
	<keyword>Endoscopic retrograde cholangiopancreatography</keyword>
	<keyword>Cholangiopancreatography , Endoscopic Retrograde</keyword>
	<keyword>ERCP</keyword>
	<keyword>High Volume</keyword>
	<keyword>Lactated Ringer</keyword>
	<keyword>Intravenous Administration</keyword>
	<keyword>Sphincterotomy , Endoscopic</keyword>
	<keyword>Pancreas</keyword>
</DOC>